PRESS-RELEASE ·Filed Apr 6, 2026

ONMD

OneMedNet Corporation
BULLISH
Impact 8/10
Horizonweeks Processed5mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight ▲ Bullish

Focus on upcoming customer conversions and 2026 revenue trajectory — early platform feedback and high-value pipeline suggest strong subscription growth potential. Monitor cash flow and gross margins as scale increases.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
ONMD ▼ -23.42% at T+60d
LONG call ✗ call lost -23.42% · α vs SPY -36.89% · entry $0.9520 → $0.7290
Entry anchored
Apr 2, 03:57 PM ET
via exchange tick
T+1d
-7.56%
call -7.56% · α -7.63%
$0.8800
settled 6mo ago
T+5d
-6.51%
call -6.51% · α -10.65%
$0.8900
settled 6mo ago
T+20d
+10.29%
call +10.29% · α +1.31%
$1.05
settled 5mo ago
T+60d
-23.42%
call -23.42% · α -36.89%
$0.7290
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

OneMedNet reported strong 2025 financial results with Real-World Data (RWD) revenue surging 329% year-over-year to $1.25M and Q4 revenue exceeding $890K, while reducing total liabilities by 74% and improving its equity position. The company is transitioning to a scalable subscription model powered by its AI-driven iRWD™ platform on Palantir Foundry, with multiple pilot customers and a growing pipeline.

Key Financial Metrics

Revenue
$1.3M
est $0.00 · +329.0% YoY

Key Facts

  • RWD revenue grew 329% YoY from $292K in 2024 to $1.254M in 2025
  • Q4 2025 revenue exceeded $890,000, indicating strong acceleration
  • Total liabilities dropped 74% from $19.7M to $5.1M, driven by debt-to-equity conversions and settlements
  • Shareholder deficit improved from $(16.0M) to $(3.0M)
  • Two pilot customers in contracting, four more expected in 2026, each with seven-figure subscription potential
  • Platform projected to grow 4x by end of 2026; early feedback shows cohort discovery reduced from weeks to minutes

Financial Impact

Revenue increased by $962,000 YoY; liability reduction of $14.6M improves financial stability

revenueliabilitiesequitysubscriptionRevenue

Risk Factors

  • Forward-looking statements subject to execution risk
  • Dependence on Palantir integration and platform scalability
  • Small revenue base means volatility likely until sustained growth is proven

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3268445
7 reports for ONMD
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ONMD — sortable, filterable
TypeNow
Jul 24, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$0.6059 $0.5901▼ −2.61%▼ −5.91%$5.39 (+789.59%)
Jul 13, 2026
11w ago
EFFECT
NEUTRAL ★ 3/10
$0.7457 $0.6600▼ −11.49%▼ −14.68%$5.39 (+622.81%)
Jun 17, 2026
15w ago
Insider Cluster
BULLISH ★ 6/10
$0.6023 $0.6901▲ +14.58%▲ +13.26%$5.39 (+794.90%)
Jun 16, 2026
15w ago
Insider Cluster
BULLISH ★ 6/10
$0.5011 $0.7267▲ +45.02%▲ +44.82%$5.39 (+975.63%)
Apr 6, 2026
25w ago
Press Release
BULLISH ★ 8/10
$0.9520 $1.05▲ +10.29%▲ +1.31%$5.39 (+466.18%)
Apr 1, 2026
26w ago
Press Release
NEUTRAL ★ 4/10
$0.8440 $1.08▲ +27.96%▲ +18.24%$5.39 (+538.63%)
Mar 18, 2026
28w ago
Press Release
MIXED ★ 5/10
$0.8190 $0.8870▲ +8.30%▲ +2.26%$5.39 (+558.12%)
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (38h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 6, 2026